Showing results (181-190 of 227) with videos related to

Sort By:
Pageof 23
The AAPS Journal|August 29, 2020
Item Response Theory Modeling of the International Prostate Symptom Score in Patients with Lower Urinary Tract Symptoms Associated with Benign Prostatic HyperplasiaYassine Kamal Lyauk, Daniël M Jonker, Trine Meldgaard Lund, et al.
Pharmaceutical Research|February 17, 2017
Maturation of Oxycodone Pharmacokinetics in Neonates and Infants: a Population Pharmacokinetic Model of Three Clinical TrialsPyry Välitalo, Merja Kokki, Veli-Pekka Ranta, et al.
The AAPS Journal|July 31, 2020
Integrated Item Response Theory Modeling of Multiple Patient-Reported Outcomes Assessing Lower Urinary Tract Symptoms Associated with Benign Prostatic HyperplasiaYassine Kamal Lyauk, Trine Meldgaard Lund, Andrew C Hooker, et al.
Clinical Pharmacokinetics|December 13, 2016
A Population Pharmacokinetic Model for 51Cr EDTA to Estimate Renal FunctionIsabelle H S Kuan, Stephen B Duffull, Tracey L Putt, et al.
The AAPS Journal|February 25, 2021
Bounded Integer Modeling of Symptom Scales Specific to Lower Urinary Tract Symptoms Secondary to Benign Prostatic HyperplasiaYassine Kamal Lyauk, Daniël M Jonker, Andrew C Hooker, et al.
The AAPS Journal|March 29, 2018
Correction to: Model-Based Adaptive Optimal Design (MBAOD) Improves Combination Dose Finding Designs: an Example in OncologyPhilippe B Pierrillas, Sylvain Fouliard, Marylore Chenel, et al.
CPT: Pharmacometrics & Systems Pharmacology|May 21, 2024
Item performance of the scale for the assessment and rating of ataxia in rare and ultra-rare genetic ataxiasAlzahra Hamdan, Andrew C Hooker, Xiaomei Chen, et al.
The AAPS Journal|March 9, 2018
Model-Based Adaptive Optimal Design (MBAOD) Improves Combination Dose Finding Designs: an Example in OncologyPhilippe B Pierrillas, Sylvain Fouliard, Marylore Chenel, et al.
Plos One|August 8, 2013
A randomized pilot study of L-arginine infusion in severe falciparum malaria: preliminary safety, efficacy and pharmacokineticsTsin W Yeo, Daniel A Lampah, Indri Rooslamiati, et al.
Journal of Clinical Pharmacology|May 6, 2011
Application of the optimal design approach to improve a pretransplant drug dose finding design for ciclosporinStefanie Hennig, Joakim Nyberg, Samuel Fanta, et al.
Pageof 23